NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

Robert J Motzer¹, Eric Jonasch², M Dror Michaelson³, Lakshminarayanan Nandagopal⁴, John L Gore⁵, Saby George⁶, Ajjai Alva⁷, Naomi Haas⁸, Michael R Harrison⁹, Elizabeth R Plimack¹⁰, Jeffrey Sosman¹¹, Neeraj Agarwal¹², Sam Bhayani¹³, Toni K Choueiri¹⁴, Brian A Costello¹⁵, Ithaar H Derweesh¹⁶, Thomas H Gallagher⁵, Steven L Hancock¹⁷, Christos Kyriakopoulos¹⁸, Chad LaGrange¹⁹, Elaine T Lam²⁰, Clayton Lau²¹, Bryan Lewis²², Brandon Manley²³, Brittany McCreery⁵, Andrew McDonald⁴, Amir Mortazavi²⁴, Phillip M Pierorazio²⁵, Lee Ponsky²⁶, Bruce G Redman⁷, Bradley Somer²⁷, Geoffrey Wile²⁸, Mary A Dwyer; CGC²⁹; Lydia J Hammond²⁹, Griselda Zuccarino-Catania²⁹

Affiliations

¹ Memorial Sloan Kettering Cancer Center.
² The University of Texas MD Anderson Cancer Center.
³ Massachusetts General Hospital Cancer Center.
⁴ O'Neal Comprehensive Cancer Center at UAB.
⁵ Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
⁶ Roswell Park Comprehensive Cancer Center.
⁷ University of Michigan Rogel Cancer Center.
⁸ Abramson Cancer Center at the University of Pennsylvania.
⁹ Duke Cancer Institute.
¹⁰ Fox Chase Cancer Center.
¹¹ Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
¹² Huntsman Cancer Institute at the University of Utah.
¹³ Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
¹⁴ Dana-Farber/Brigham and Women's Cancer Center.
¹⁵ Mayo Clinic Cancer Center.
¹⁶ UC San Diego Moores Cancer Center.
¹⁷ Stanford Cancer Institute.
¹⁸ University of Wisconsin Carbone Cancer Center.
¹⁹ Fred & Pamela Buffett Cancer Center.
²⁰ University of Colorado Cancer Center.
²¹ City of Hope National Medical Center.
²² Kidney Cancer Coalition.
²³ Moffitt Cancer Center.
²⁴ The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
²⁵ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
²⁶ Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
²⁷ St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
²⁸ Vanderbilt-Ingram Cancer Center; and.
²⁹ National Comprehensive Cancer Network.

PMID: 31693980
DOI: 10.6004/jnccn.2019.0054

Practice Guideline

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

Robert J Motzer et al. J Natl Compr Canc Netw. 2019.

. 2019 Nov 1;17(11):1278-1285.

doi: 10.6004/jnccn.2019.0054.

Authors

Affiliations

¹ Memorial Sloan Kettering Cancer Center.
² The University of Texas MD Anderson Cancer Center.
³ Massachusetts General Hospital Cancer Center.
⁴ O'Neal Comprehensive Cancer Center at UAB.
⁵ Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
⁶ Roswell Park Comprehensive Cancer Center.
⁷ University of Michigan Rogel Cancer Center.
⁸ Abramson Cancer Center at the University of Pennsylvania.
⁹ Duke Cancer Institute.
¹⁰ Fox Chase Cancer Center.
¹¹ Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
¹² Huntsman Cancer Institute at the University of Utah.
¹³ Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
¹⁴ Dana-Farber/Brigham and Women's Cancer Center.
¹⁵ Mayo Clinic Cancer Center.
¹⁶ UC San Diego Moores Cancer Center.
¹⁷ Stanford Cancer Institute.
¹⁸ University of Wisconsin Carbone Cancer Center.
¹⁹ Fred & Pamela Buffett Cancer Center.
²⁰ University of Colorado Cancer Center.
²¹ City of Hope National Medical Center.
²² Kidney Cancer Coalition.
²³ Moffitt Cancer Center.
²⁴ The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
²⁵ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
²⁶ Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
²⁷ St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
²⁸ Vanderbilt-Ingram Cancer Center; and.
²⁹ National Comprehensive Cancer Network.

PMID: 31693980
DOI: 10.6004/jnccn.2019.0054

Abstract

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Sheridan PubFactory
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

Affiliations

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

Authors

Affiliations

Abstract

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical